Skip to main content

Retrospective study of 41 pts w/ refractory inflammatory myositis treated with tofacitinib; (23 DM, 12 CADM & 6 PM).

Aug 29, 2023 10:00 am
Social Author Name
RheumNow
Tweet Content
Retrospective study of 41 pts w/ refractory inflammatory myositis treated with tofacitinib; (23 DM, 12 CADM & 6 PM). In ALL pts - no improvement in strength observed, but Skin did improve! 54% discontinued TOFA for lack of benefit or death. https://t.co/NPgdeOuw8C https://t.co/jBSqhSk29Y
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×